Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann M Ginsberg

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Expert Review of Vaccines|March 21, 2019
Designing tuberculosis vaccine efficacy trials - lessons from recent studiesAnn M Ginsberg
Tuberculosis (Edinburgh, Scotland)|April 13, 2010
Tuberculosis drug development: progress, challenges, and the road aheadAnn M Ginsberg
Bulletin of the World Health Organization|July 20, 2002
What's new in tuberculosis vaccines?Ann M Ginsberg
Drugs|November 18, 2010
Drugs in development for tuberculosisAnn M Ginsberg
Seminars in Respiratory and Critical Care Medicine|September 24, 2008
Emerging drugs for active tuberculosisAnn M Ginsberg
Nature Medicine|March 8, 2007
Challenges in tuberculosis drug research and developmentAnn M Ginsberg, Melvin Spigelman
Seminars in Immunology|December 6, 2020
Key recent advances in TB vaccine development and understanding of protective immune responses against Mycobacterium tuberculosisThomas J Scriba, Mihai G Netea, Ann M Ginsberg
Tuberculosis (Edinburgh, Scotland)|July 30, 2016
TB vaccines in clinical developmentAnn M Ginsberg, Morten Ruhwald, Helen Mearns, et al.
Molecular and Cellular Biology|April 10, 2002
Conserved furin cleavage site not essential for secretion and integration of ZP3 into the extracellular egg coat of transgenic miceMing Zhao, Lyn Gold, Ann M Ginsberg, et al.
Lancet (London, England)|March 18, 2008
The ethics of non-inferiority trialsAndrew J Nunn, Sarah K Meredith, Melvin K Spigelman, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Expert Review of Vaccines|March 21, 2019
Designing tuberculosis vaccine efficacy trials - lessons from recent studiesAnn M Ginsberg
Tuberculosis (Edinburgh, Scotland)|April 13, 2010
Tuberculosis drug development: progress, challenges, and the road aheadAnn M Ginsberg
Bulletin of the World Health Organization|July 20, 2002
What's new in tuberculosis vaccines?Ann M Ginsberg
Drugs|November 18, 2010
Drugs in development for tuberculosisAnn M Ginsberg
Seminars in Respiratory and Critical Care Medicine|September 24, 2008
Emerging drugs for active tuberculosisAnn M Ginsberg
Nature Medicine|March 8, 2007
Challenges in tuberculosis drug research and developmentAnn M Ginsberg, Melvin Spigelman
Seminars in Immunology|December 6, 2020
Key recent advances in TB vaccine development and understanding of protective immune responses against Mycobacterium tuberculosisThomas J Scriba, Mihai G Netea, Ann M Ginsberg
Tuberculosis (Edinburgh, Scotland)|July 30, 2016
TB vaccines in clinical developmentAnn M Ginsberg, Morten Ruhwald, Helen Mearns, et al.
Molecular and Cellular Biology|April 10, 2002
Conserved furin cleavage site not essential for secretion and integration of ZP3 into the extracellular egg coat of transgenic miceMing Zhao, Lyn Gold, Ann M Ginsberg, et al.
Lancet (London, England)|March 18, 2008
The ethics of non-inferiority trialsAndrew J Nunn, Sarah K Meredith, Melvin K Spigelman, et al.
Pageof 3